| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |